FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Englebright Jane D.
2. Issuer Name and Ticker or Trading Symbol

HCA Healthcare, Inc. [ HCA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
SVP and Chief Nursing Officer
(Last)          (First)          (Middle)

ONE PARK PLAZA
3. Date of Earliest Transaction (MM/DD/YYYY)

7/27/2021
(Street)

NASHVILLE, TN 37203
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 7/27/2021  M  3300 A$47.97 6809 D  
Common Stock 7/27/2021  M  5500 A$68.96 12309 D  
Common Stock 7/27/2021  F  4782 D$247.69 7527 D  
Common Stock 7/29/2021  S  200 D$249.36 (1)7327 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Appreciation Right $47.97 7/27/2021  M     1375   (2)2/5/2024 Common Stock 1375 $0.00 0 D  
Stock Appreciation Right $47.97 7/27/2021  M     1925   (3)2/5/2024 Common Stock 1925 $0.00 0 D  
Stock Appreciation Right $68.96 7/27/2021  M     5500   (4)2/4/2025 Common Stock 5500 $0.00 0 D  

Explanation of Responses:
(1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.30 to $249.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(2) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
(3) The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
(4) The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Englebright Jane D.
ONE PARK PLAZA
NASHVILLE, TN 37203


SVP and Chief Nursing Officer

Signatures
/s/ Kevin A. Ball, Attorney-in-Fact7/29/2021
**Signature of Reporting PersonDate

HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more HCA Healthcare Charts.
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more HCA Healthcare Charts.